Short answer · Medically reviewed summary · Last updated: 2023-07-13
Primary Intestinal Lymphangiectasia (PIL) is a rare disorder characterized by abnormal dilation of the lymphatic vessels in the small intestine. It is also known as Waldmann's disease or Waldmann's syndrome.
What is the prevalence of Primary Intestinal Lymphangiectasia?
Prevalence of Primary Intestinal Lymphangiectasia: how many people are affected worldwide, differences by sex and region, with sources.
Primary Intestinal Lymphangiectasia (PIL) is a rare disorder characterized by abnormal dilation of the lymphatic vessels in the small intestine. It is also known as Waldmann's disease or Waldmann's syndrome. PIL is considered a rare condition, with an estimated prevalence of approximately 1 in 100,000 individuals.
The disorder primarily affects children and young adults, with symptoms typically appearing in infancy or early childhood. PIL is more commonly observed in females than males. The exact cause of PIL is not fully understood, but it is believed to be a result of genetic mutations that affect the development and function of the lymphatic system.
Individuals with PIL may experience a range of symptoms, including chronic diarrhea, abdominal pain, malabsorption of nutrients, and weight loss. These symptoms can lead to nutritional deficiencies and growth delays if left untreated. Diagnosis of PIL involves various tests, such as endoscopy, imaging studies, and analysis of intestinal biopsies.
Treatment for PIL focuses on managing symptoms and preventing complications. This typically involves dietary modifications, including a low-fat, high-protein diet and the supplementation of essential nutrients. In some cases, medications may be prescribed to control symptoms and reduce inflammation in the intestines.
While PIL is a rare condition, early diagnosis and appropriate management can significantly improve the quality of life for individuals affected by this disorder.
